Stock BOTH BIOETHICS, LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Bioethics, Ltd.

Equities

BOTH

US09059E2090

Investment Holding Companies

Market Closed - OTC Markets
Other stock markets
 03:18:05 2024-04-30 pm EDT 		5-day change 1st Jan Change
1.2 USD +471.16% Intraday chart for Bioethics, Ltd. -.--% +471.16%
Apr. 11 Bioethics, Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Bioethics, Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 4.4 7.7 1.305 2.157 0.2952 0.2385
Enterprise Value (EV) 1 4.619 7.995 1.669 2.552 0.7154 0.6811
P/E ratio -166 x -75.6 x -11 x -20.1 x -3.17 x -2.46 x
Yield - - - - - -
Capitalization / Revenue - - - - - -
EV / Revenue - - - - - -
EV / EBITDA -86 x -115 x -22.3 x -43.1 x -15.2 x -
EV / FCF -282 x -195 x -69.6 x 201 x 76.8 x 48.2 x
FCF Yield -0.35% -0.51% -1.44% 0.5% 1.3% 2.07%
Price to Book -16.4 x -21.1 x -2.73 x -3.68 x -0.43 x -0.31 x
Nbr of stocks (in thousands) 1,100 1,100 1,135 1,135 1,135 1,135
Reference price 2 4.000 7.000 1.150 1.900 0.2600 0.2101
Announcement Date 3/19/19 4/9/20 4/15/21 4/15/22 4/17/23 4/11/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales - - - - - -
EBITDA 1 -0.0537 -0.0697 -0.0749 -0.0591 -0.0471 -
EBIT 1 -0.054 -0.07 -0.0751 -0.0594 -0.0473 -0.0504
Operating Margin - - - - - -
Earnings before Tax (EBT) 1 -0.0735 -0.1019 -0.1192 -0.1072 -0.0932 -0.0971
Net income 1 -0.0735 -0.1019 -0.1192 -0.1072 -0.0932 -0.0971
Net margin - - - - - -
EPS 2 -0.0241 -0.0926 -0.1050 -0.0944 -0.0821 -0.0856
Free Cash Flow 1 -0.0164 -0.041 -0.024 0.0127 0.009312 0.0141
FCF margin - - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 3/19/19 4/9/20 4/15/21 4/15/22 4/17/23 4/11/24
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 0.22 0.29 0.36 0.39 0.42 0.44
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) -4.083 x -4.226 x -4.869 x -6.673 x -8.928 x -
Free Cash Flow 1 -0.02 -0.04 -0.02 0.01 0.01 0.01
ROE (net income / shareholders' equity) 32.5% 32.2% 28.2% 20.1% 14.7% 13.4%
ROA (Net income/ Total Assets) -181% -210% -924% -4,564% -5,752% -14,595%
Assets 1 0.0407 0.0486 0.0129 0.002349 0.00162 0.000666
Book Value Per Share 2 -0.2400 -0.3300 -0.4200 -0.5200 -0.6000 -0.6800
Cash Flow per Share 2 0.0300 0.0100 0 0 0 0
Capex - - - - - -
Capex / Sales - - - - - -
Announcement Date 3/19/19 4/9/20 4/15/21 4/15/22 4/17/23 4/11/24
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Shell Companies

1st Jan change Capi.
BIOETHICS, LTD. Stock Bioethics, Ltd.
+471.16% 1.36M
TRUMP MEDIA & TECHNOLOGY GROUP CORP. Stock Trump Media & Technology Group Corp.
+178.17% 6.17B
SCREAMING EAGLE ACQUISITION CORP. Stock Screaming Eagle Acquisition Corp.
-6.60% 998M
CHURCHILL CAPITAL CORP VII Stock Churchill Capital Corp VII
+2.00% 982M
APPLE ISPORTS GROUP, INC. Stock Apple iSports Group, Inc.
+41.91% 872M
PERELLA WEINBERG PARTNERS Stock Perella Weinberg Partners
+22.85% 803M
ARES ACQUISITION CORPORATION II Stock Ares Acquisition Corporation II
+1.82% 663M
ALTC ACQUISITION CORP. Stock AltC Acquisition Corp.
+21.31% 601M
DA ZHONG TRADING GROUP HOLDING COMPANY Stock Da Zhong Trading Group Holding Company
-.--% 600M
E7 GROUP Stock E7 Group
-90.22% 596M
Shell Companies
  1. Stock Market
  2. Equities
  3. BOTH Stock
  4. Financials Bioethics, Ltd.